Şirket duyuruları · 14.11.20261 dk okuma
Innovent Announces Seven Innovative Products Including Mazdutide and PECONDLE® Successfully Included in the 2026 National Reimbursement Drug List
Yerel otomatik çeviri · Kaynağın orijinal dili
Özet
PALO ALTO, Calif. and SUZHOU, China, Nov. 14, 2026 — Innovent Biologics, Inc.